Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 602
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01434550 | Phase II Study of First-line SBRT in Patients With Non-Metastatic Unresectable Pancreatic Cancer | ||
| NCT03424837 | A Survivorship Care Plan and Embedded Navigation Tool | ||
| NCT02586675 | TEEL Study- Phase 1 Tamoxifen and Ribociclib (LEE011) in Advanced ER+ (HER2 Negative) Breast Cancer | ||
| NCT05093608 | SELINEXOR in Combination w/Bevacizumab and Atezolizumab in Newly Diagnosed Advanced Hepatocellular Carcinoma | ||
| NCT06378047 | Irreversible Electroporation & Pembro Immunotherapy in Locally Advanced Pancreatic Cancer | ||
| NCT02139358 | Phase I/IIa Trial of Gemcitabine Plus Trastuzumab and Pertuzumab in Previously Treated Metastatic HER2+ Breast Cancer | ||
| NCT02402764 | Phase 2 Trial of Selinexor (KPT-330) for Metastatic Triple Negative Breast Cancer (TNBC) | ||
| NCT03509467 | Using MC1R Genotype to Impact Melanoma Risk Behavior | ||
| NCT00005792 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma | ||
| NCT03904199 | Prospective Study of Personalized Approach to Inpatient Patients With Hyperglycemia | ||
| NCT01198821 | Gem-TABS in Unresectable Pancreatic Carcinoma | ||
| NCT04996823 | Axitinib + Ipilimumab in Advanced Melanoma | ||
| NCT00226590 | Induction Gemcitabine & Carboplatin Followed by Paclitaxel & Carboplatin +XRT in NSCLC | ||
| NCT01350583 | Bicarbonate for Tumor Related Pain | ||
| NCT05064423 | Clinical Trials Outreach & Education | ||
| NCT07542041 | Artidis Nanomechanical Signature Profiling of Pancreatic Cancer Specimens | ||
| NCT01042535 | Vaccine Therapy and 1-MT in Treating Patients With Metastatic Breast Cancer | ||
| NCT04388839 | Evolutionary Therapy for Rhabdomyosarcoma | ||
| NCT04275557 | Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas | ||
| NCT01176461 | Multiple Class I Peptides & Montanide ISA 51 VG w Escalating Doses of Anti-PD-1 ab BMS936558 | ||
| NCT03177291 | Pirfenidone Combined With Standard First-Line Chemotherapy in Advanced-Stage Lung NSCLC | ||
| NCT02450708 | Selection of Allogeneic Hematopoietic Cell Donors Based on KIR and HLA Genotypes | ||
| NCT06350318 | Rituximab and Zanubrutinib in Patients With Indolent B-cell Lymphomas | ||
| NCT04610671 | Study of CG0070 Combined With Nivolumab in Cisplatin Ineligible Patients With MIBC | ||
| NCT03411031 | Elotuzumab Plus Lenalidomide (Elo/Rev) for Serologic Relapse/Progression While on Lenalidomide | ||
| NCT06328127 | Positive Psychology Intervention for Hematopoietic Stem Cell Transplantation Survivors | ||
| NCT01999985 | Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC) | ||
| NCT06691035 | Immunologic Targeting of ESR1 Receptor for Hormone Receptor Expressing Metastatic Breast Cancer | ||
| NCT03078361 | Latinos CARES (Colorectal Cancer Awareness, Research, Education and Screening) | ||
| NCT03290079 | Phase II Study of Pembrolizumab and Lenvatinib in Advanced Well-differentiated Neuroendocrine Tumors | ||
| NCT06833502 | Phase II Study of Systemic Screening in Pathologic Node Positive Breast Cancer | ||
| NCT00868114 | Direct Tumor Injection KLH-Pulsed Dendritic Cells in Unresectable Pancreatic Cancer | ||
| NCT04538482 | DASH INtervention to INvestigate the Gut | ||
| NCT02592447 | Cognitive Behavioral Intervention for Targeted Therapy Fatigue (CBT-TTF) Intervention | ||
| NCT04766164 | Health Beliefs, Behaviors, and Healthcare Experiences Among United States Young and Mid-Age Adults | ||
| NCT00365599 | Phase II Trial of SAHA & Tamoxifen for Patients With Breast Cancer | ||
| NCT00006085 | CP-609,754 in Treating Patients With Advanced Solid Tumors | ||
| NCT06764992 | Exploring Men s Prostate Cancer Genetic Risk Perceptions | ||
| NCT04300855 | Clinical Trial of Green Tea Catechins in Men on Active Surveillance | ||
| NCT05524935 | Olaparib in Combination With Pembrolizumab for Advanced Uveal Melanoma | ||
| NCT07352943 | Development of a Mindfulness-Based Smartphone Application for BMT Caregivers | ||
| NCT02943642 | Safety and Effectiveness of A-dmDT390-bisFv(UCHT1) Fusion Protein in Subjects With Mycosis Fungoides | ||
| NCT03628144 | Immunonutrition to Reduce Toxicities in Non-Small Cell Lung Cancer | ||
| NCT05271630 | Multiple Myeloma Outcomes Based on Maintenance Therapy Post Autologous Stem Cell Transplant | ||
| NCT06048822 | Enhancing Cancer Survivorship With Pickleball | ||
| NCT03511196 | Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate Cancer | ||
| NCT01416168 | Pilot Study of a Geriatric Intervention After Colorectal and Lung Cancer Surgery | ||
| NCT02328807 | Focal Prostate Radio-Frequency Ablation | ||
| NCT06047977 | Tumor Infiltrating Lymphocyte Therapy for Pediatric High Risk Solid Tumors | ||
| NCT06760156 | Tafasitamab and Lenalidomide as First Salvage Therapy for Residual Large B Cell Lym |
